Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H2 2018

US$ 3,500.00

... Somatostatin Receptor Type 2 (SRIF1 or SSTR2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 64 pages

Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2018

US$ 3,500.00

... Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 62 pages

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2018

US$ 3,500.00

... Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 73 pages

Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) - Pipeline Review, H2 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) development landscape Develop and design ...

September 2018 47 pages

Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Pipeline Review, H2 2018

US$ 3,500.00

... Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 32 pages

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2018

US$ 3,500.00

... reviews Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 53 pages

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2018

US$ 3,500.00

... Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 150 pages

Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H2 2018

US$ 3,500.00

... Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 72 pages

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H2 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) development landscape Develop and design ...

September 2018 128 pages

Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H2 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) development landscape Develop and design ...

September 2018 83 pages

Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H2 2018

US$ 3,500.00

... Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 74 pages

Antipsychotic Drugs: Technologies and Global Markets

US$ 2,750.00

... market for antipsychotic drugs. The report highlights the current and future market potential of antipsychotic drugs and provides a detailed analysis of the competitive environment, regulatory scenario, technological ... of the global market for antipsychotic drugs Analyses of global market trends, with data from ...

September 2018 174 pages

Global Growth Factors (Blood and Tissue) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... There are 15 Chapters to deeply display the global Growth Factors (Blood and Tissue) market. Chapter 1, to describe Growth Factors (Blood and Tissue) Introduction, product scope, market overview ...

September 2018 136 pages

Global Heart Healthy Ingredients Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... display the global Heart Healthy Ingredients market. Chapter 1, to describe Heart Healthy Ingredients Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Heart Healthy Ingredients, with ...

September 2018 139 pages

Global Transdermal Drug Delivery Systems Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... the Report: This report focuses on the Transdermal Drug Delivery Systems in global market, especially in North America, Europe and ... Chapters to deeply display the global Transdermal Drug Delivery Systems market. Chapter 1, to describe Transdermal Drug Delivery Systems Introduction, product scope, market ...

September 2018 136 pages

Investigation Report on China's Gliclazide Market, 2018-2022

US$ 2,200.00

... of Servier, the company has been taking the leading position on China's Gliclazide market. Also dominating the market are Servier and Servier ... rising after the drug entered China, and exceeded CNY 200 million in 2017. It is expected that China's Gliclazide market will continue to grow as the ...

September 2018 30 pages

Investigation Report on China's Irbesartan Market, 2018-2022

US$ 2,200.00

... of China's Irbesartan market Market demand for Irbesartan in China Analysis on competition on China's Irbesartan market Analysis on major Irbesartan manufacturers in China Driving forces for China's Irbesartan market from 2018 to 2022 Prospect of China's Irbesartan ...

September 2018 30 pages

Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) – World Forecasts to 2022

US$ 1,600.00

... of channels with lowest dimensions. The report “Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro ... 2017-2022). The new report also focuses on microfluidics market by material, such as ceramics, polymers, glass, and silicon; ...

September 2018 90 pages

Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... Others There are 15 Chapters to deeply display the global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market. Chapter 1, to describe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction, product scope, market overview, market ...

September 2018 100 pages

Global Intravenous (IV) Solutions Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... : This report focuses on the Intravenous (IV) Solutions in global market, especially in North America, Europe ... the global Intravenous (IV) Solutions market. Chapter 1, to describe Intravenous (IV) Solutions Introduction, product scope, market overview, market opportunities, market risk, market driving force ...

September 2018 118 pages

Global Tablet & Pellet Coating Systems Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... of the Report: This report focuses on the Tablet & Pellet Coating Systems in global market, especially in North America, Europe and Asia ... 15 Chapters to deeply display the global Tablet & Pellet Coating Systems market. Chapter 1, to describe Tablet & Pellet Coating Systems Introduction, product scope, market ...

September 2018 122 pages

Global Drug Repurposing Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Drug Repurposing, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...

September 2018 115 pages

Global Ebola Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Ebola Treatment, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...

September 2018 123 pages

Investigation Report on China's Lamivudine Market, 2018-2022

US$ 2,200.00

... : Development environment of China's Lamivudine market Size of China's Lamivudine market Competition pattern of China's Lamivudine market Prices of Lamivudine in China Driving forces and opportunities for China's Lamivudine market Prospect of China's Lamivudine market from ...

September 2018 30 pages

Investigation Report on China's Sildenafil Market, 2018-2022

US$ 2,200.00

... the approval. Therefore, Chinese manufacturers began to launch Sildenafil in 2014. CRI's market investigation shows that China's Sildenafil market is dominated by Pfizer's Viagra, Baiyunshan's Jinge ...

September 2018 30 pages

Cedar Pollen Allergy - Pipeline Review, H2 2018

US$ 2,000.00

... releases. The Cedar Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Cedar Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2018 38 pages

5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H2 2018

US$ 3,500.00

... 5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 63 pages

Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H2 2018

US$ 3,500.00

... Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 48 pages

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2018

US$ 3,500.00

... Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 83 pages

Macrophage Migration Inhibitory Factor (Glycosylation Inhibiting Factor or L Dopachrome Isomerase or L Dopachrome Tautomerase or Phenylpyruvate Tautomerase or MIF or EC 5.3.2.1 or EC 5.3.3.12) - Pipeline Review, H2 2018

US$ 3,500.00

... /Universities. It also reviews key players involved in Macrophage Migration Inhibitory Factor (Glycosylation Inhibiting Factor or L Dopachrome Isomerase or L Dopachrome Tautomerase or Phenylpyruvate Tautomerase or MIF or EC 5.3.2.1 or EC 5.3.3.12) targeted therapeutics development with respective active and ...

September 2018 70 pages

Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Pipeline Review, H2 2018

US$ 3,500.00

... Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 110 pages

Connective Tissue Growth Factor (CCN Family Member 2 or Hypertrophic Chondrocyte Specific Protein 24 or Insulin Like Growth Factor Binding Protein 8 or IGFBP8 or CTGF) - Pipeline Review, H2 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Connective Tissue Growth Factor (CCN Family Member 2 or Hypertrophic Chondrocyte Specific Protein 24 or Insulin Like Growth Factor Binding Protein 8 or IGFBP8 or CTGF) development ...

September 2018 79 pages

High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) - Pipeline Review, H2 2018

US$ 3,500.00

... High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 46 pages

Huntingtin (Huntington Disease Protein or HTT) - Pipeline Review, H2 2018

US$ 3,500.00

... Huntingtin (Huntington Disease Protein or HTT) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 64 pages

Kinesin Like Protein KIF11 (Kinesin Like Protein 1 or Kinesin Like Spindle Protein HKSP or Kinesin Related Motor Protein Eg5 or Thyroid Receptor Interacting Protein 5 or TRIP5 or EG5 or KIF11) - Pipeline Review, H2 2018

US$ 3,500.00

... /Universities. It also reviews key players involved in Kinesin Like Protein KIF11 (Kinesin Like Protein 1 or Kinesin Like Spindle Protein HKSP or Kinesin Related Motor Protein Eg5 or Thyroid Receptor Interacting Protein 5 or TRIP5 or EG5 or KIF11) targeted therapeutics development with respective active and ...

September 2018 58 pages

Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) - Pip Review, H2 2018

US$ 3,500.00

... Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 39 pages

Global Vitamin B6 (Pyridoxine Hydrochloride) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... Industry Others There are 15 Chapters to deeply display the global Vitamin B6 (Pyridoxine Hydrochloride) market. Chapter 1, to describe Vitamin B6 (Pyridoxine Hydrochloride) Introduction, product scope, market overview, market opportunities ...

September 2018 131 pages

2018 Leading Animal Health Companies: Marketing Tactics, Technological Know-How and Global Sales Segment Forecasts

US$ 3,450.00

This new report from VPGMarketResearch.com provides global animal health market outlook and leading suppliers strategies, marketing tactics, and technological know- ... drug screening, tissue engineering, bioinformatics and other technologies. The company profiles include: Sales force size in the U.S. and other ...

September 2018 80 pages

2018 Leading Animal Health Companies: Strategies, Marketing Tactics, Technological Know-How and Global Sales Segment Forecasts

US$ 4,850.00

... new report from VPGMarketResearch.com provides global animal health market outlook and leading suppliers strategies, marketing tactics, and technological ... screening, tissue engineering, bioinformatics and other technologies. The company profiles include: Specific business, new product development and ...

September 2018 110 pages

2018 Leading Animal Health Companies: Business Strategies, Marketing Tactics and Global Sales Segment Forecasts

US$ 3,450.00

... new report from VPGMarketResearch.com provides global animal health market outlook and leading suppliers strategies, marketing tactics, and technological ... screening, tissue engineering, bioinformatics and other technologies. The company profiles include: Specific business, new product development and ...

September 2018 80 pages

Global Tea Tree Oil Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... display the global Tea Tree Oil market. Chapter 1, to describe Tea Tree Oil Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Tea Tree Oil, with ...

September 2018 134 pages

Global Ursodeoxycholic Acid Drug Product Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... the Report: This report focuses on the Ursodeoxycholic Acid Drug Product in global market, especially in North America, Europe ... to deeply display the global Ursodeoxycholic Acid Drug Product market. Chapter 1, to describe Ursodeoxycholic Acid Drug Product Introduction, product scope, market overview, market ...

September 2018 132 pages

Global Foot and Mouth Disease (FMD) Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... of the Report: This report focuses on the Foot and Mouth Disease (FMD) Vaccines in global market, especially in North America, Europe and ... 15 Chapters to deeply display the global Foot and Mouth Disease (FMD) Vaccines market. Chapter 1, to describe Foot and Mouth Disease (FMD) Vaccines Introduction, product ...

September 2018 152 pages

Global Compounding Pharmacy Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Compounding Pharmacy, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...

September 2018 134 pages

Global Tuberculosis Diagnostics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Tuberculosis Diagnostics, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze ...

September 2018 136 pages

Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis

US$ 300.00

Aruvian Research analyzes the Pharmaceutical Industry in United States in the Michael Porter’s Five Forces Analysis. It uses concepts ...

September 2018 40 pages

Analyzing the Global Market for Active Pharmaceutical Ingredients 2018

US$ 1,200.00

... and the impacts on the industry. Key markets analyzed in Asia Pacific include China, India, Japan ... Europe and the impacts on the industry. Key markets analyzed in Europe include France, Germany, Italy, ... America and the impacts on the industry. Key markets analyzed in North America include Canada and the United ...

September 2018 425 pages

Active Pharmaceutical Ingredients - Global Market Outlook (2017-2026)

US$ 4,150.00

... , treatment and prevention of diseases. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine ...

August 2018 151 pages

PET Pharmaceutical Packaging - Global Market Outlook (2017-2026)

US$ 4,150.00

According to Stratistics MRC, the PET Pharmaceutical Packaging market is accounted for $14.36 billion in 2017 and is expected to reach $45.12 billion by ... labelling applications in this region. Some of the key players in the PET Pharmaceutical Packaging market include Sappi Ltd, Nippon Paper Group, Inc, Nalco ...

August 2018 160 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1